{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:20:09Z","timestamp":1794932409474,"version":"4.9.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["408685\/2024\\u20137"],"award-info":[{"award-number":["408685\/2024\\u20137"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/05664\\u20139"],"award-info":[{"award-number":["2024\/05664\\u20139"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/13004\\u20130"],"award-info":[{"award-number":["2021\/13004\\u20130"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/08943\\u20135"],"award-info":[{"award-number":["2020\/08943\\u20135"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["0343\/20"],"award-info":[{"award-number":["0343\/20"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129073","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T21:06:07Z","timestamp":1787432767000},"page":"129073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB\/c mice"],"prefix":"10.1016","volume":"91","author":[{"given":"Jo\u00e3o Pedro da Silva","family":"Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Pazotti","family":"Daher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando da Silva","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Massao","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Bandeira","family":"Sulczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenno Fernandes da Cunha","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Moreira","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo Ferreira","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Mario Ramos","family":"Janini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Terzi","family":"Maricato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edecio","family":"Cunha- Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Beatriz","family":"Boscardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Santoro","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129073_bb0005","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41591-022-01750-1","article-title":"COVID-19 and resilience of healthcare systems in ten countries","volume":"28","author":"Arsenault","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.129073_bb0010","series-title":"WHO coronavirus disease (COVID-19) dashboard","author":"World Health Organisation","year":"2026"},{"key":"10.1016\/j.vaccine.2026.129073_bb0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129073_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9090965","article-title":"An update on mRNA-based viral vaccines","volume":"9","author":"Jeeva","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129073_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.129073_bb0030","series-title":"COVID-19 vaccine development: milestones, lessons and prospects","author":"Li","year":"2022"},{"key":"10.1016\/j.vaccine.2026.129073_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129073_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008548","article-title":"Developing a low-cost and accessible covid-19 vaccine for global health","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2026.129073_bb0045","doi-asserted-by":"crossref","unstructured":"J. Hare, R. Hesselink, A. Bongers, P. Blakeley, G. Riggall, Improving vaccine equity by increasing vaccine thermostability, (2024) 1\u20135. doi:https:\/\/doi.org\/10.1126\/scitranslmed.adm7471, Sci Transl Med.","DOI":"10.1126\/scitranslmed.adm7471"},{"key":"10.1016\/j.vaccine.2026.129073_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines12060579","article-title":"A review of protein-based COVID-19 vaccines: from monovalent to multivalent formulations","volume":"12","author":"Qian","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129073_bb0055","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.129073_bb0060","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.cell.2022.04.029","article-title":"Protective prototype-Beta and Delta-omicron chimeric RBD-dimer vaccines against SARS-CoV-2","volume":"185","author":"Xu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.129073_bb0065","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.vaccine.2023.03.035","article-title":"Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE\u2122","volume":"41","author":"Xu","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129073_bb0070","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/22221751.2022.2056524","article-title":"A tandem-repeat dimeric RBD protein-based COVID-19 vaccine ZF2001 protects mice and nonhuman primates","volume":"11","author":"An","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2026.129073_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-23942-y","article-title":"SARS-CoV-2 RBD trimer protein adjuvanted with alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung","volume":"12","author":"Routhu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.129073_bb0080","article-title":"A recombinant receptor-binding domain in trimeric form generates protective immunity against SARS-CoV-2 infection in nonhuman primates","volume":"2","author":"Yang","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.vaccine.2026.129073_bb0085","series-title":"Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine","first-page":"1","author":"Nunes","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129073_bb0090","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.vaccine.2026.129073_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1459394","article-title":"Adjuvants: classification, modus operandi, and licensing","volume":"2016","author":"Apost\u00f3lico","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2026.129073_bb0100","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1073\/pnas.1107941108","article-title":"Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88","volume":"108","author":"Seubert","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.129073_bb0105","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129073_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.abb.2018.12.022","article-title":"NOD1 and NOD2 in inflammation, immunity and disease","volume":"670","author":"Mukherjee","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.vaccine.2026.129073_bb0115","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2024.03.015","article-title":"Vaccine adjuvants: tailoring innate recognition to send the right message","volume":"57","author":"Lavelle","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.129073_bb0120","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1080\/21645515.2019.1586040","article-title":"Safety profile of the RTS,S\/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa","volume":"15","author":"Mendoza","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129073_bb0125","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.vaccine.2019.04.048","article-title":"Safety of AS03-adjuvanted influenza vaccines: a review of the evidence","volume":"37","author":"Cohet","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129073_bb0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1473-3099(13)70046-X","article-title":"AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people : a phase 3 randomised trial","author":"Mcelhaney","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129073_bb0135","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1080\/21645515.2016.1183847","article-title":"Safety of the human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in adolescents aged 12\u201315 years: interim analysis of a large community-randomized controlled trial","volume":"12","author":"Lehtinen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.129073_bb0140","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1128\/IAI.68.12.6946-6953.2000","article-title":"Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium boris BCG infection in C57BL\/6 and BALB\/c mice","volume":"68","author":"Wakeham","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.129073_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.00553","article-title":"BALB\/c and C57BL\/6 mice cytokine responses to Trypanosoma cruzi infection are independent of parasite strain infectivity","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2025.101115","article-title":"A preliminary investigation of the differences in immune responses in different strains of mice with localized allergic rhinitis tolerance models","volume":"18","author":"Zhang","year":"2025","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.vaccine.2026.129073_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112593","article-title":"CpG adjuvant enhances humoral and cellular immunity against OVA in different degrees in BALB\/c, C57BL\/6J, and C57BL\/6N mice","volume":"138","author":"Chu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/cei.12841","article-title":"The genetic background influences the cellular and humoral immune responses to vaccines","volume":"186","author":"Zeng","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110629","article-title":"Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants","volume":"611","author":"Silva","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.129073_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28481","article-title":"The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (omicron) SARS-CoV-2 variant","volume":"95","author":"Farias","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0175","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cyto.a.20646","article-title":"Optimizing peptide matrices for identifying T-cell antigens","volume":"73","author":"Precopio","year":"2008","journal-title":"Cytom Part A"},{"key":"10.1016\/j.vaccine.2026.129073_bb0180","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","article-title":"Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine","volume":"386","author":"Hager","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.129073_bb0185","article-title":"\u201cWorld in motion\u201d \u2013 emulsion adjuvants rising to meet the pandemic challenges","volume":"6","author":"O'Hagan","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.129073_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi8039","article-title":"AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans","volume":"9","author":"Grigoryan","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00472-2","article-title":"Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice","volume":"7","author":"Grigoryan","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.129073_bb0200","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1016\/j.vaccine.2023.08.054","article-title":"Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2","volume":"41","author":"Chiba","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129073_bb0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2026.129073_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071455","article-title":"Using dual toll-like receptor agonism to drive Th1-biased response in a squalene- and \u03b1-tocopherol-containing emulsion for a more effective SARS-CoV-2 vaccine","volume":"14","author":"Short","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2026.129073_bb0220","doi-asserted-by":"crossref","first-page":"21095","DOI":"10.1073\/pnas.1319784110","article-title":"The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination","volume":"110","author":"Vono","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.129073_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-018-0058-4","article-title":"Activation of the endoplasmic reticulum stress sensor IRE1\u03b1 by the vaccine adjuvant AS03 contributes to its immunostimulatory properties","volume":"3","author":"Givord","year":"2018","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.129073_bb0230","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing \u03b1-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129073_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107598","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0240","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0245","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrrheum.2014.127","article-title":"IL-6 biology: implications for clinical targeting in rheumatic disease","volume":"10","author":"Calabrese","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0250","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.it.2021.02.002","article-title":"Bcl6-mediated transcriptional regulation of follicular helper T cells (TFH)","volume":"42","author":"Choi","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0255","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.129073_bb0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cytogfr.2011.02.001","article-title":"Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses","volume":"22","author":"Yu","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2026.129073_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02017-2","article-title":"A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy","volume":"40","author":"De Waele","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2026.129073_bb0270","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri3247","article-title":"Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination","volume":"12","author":"Desmet","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type i interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0280","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/icb.2016.65","article-title":"IgG subclass co-expression brings harmony to the quartet model of murine IgG function","volume":"94","author":"Collins","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2026.129073_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106126","article-title":"Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2","volume":"26","author":"Barreiro","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.vaccine.2026.129073_bb0290","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/S1473-3099(24)00377-3","article-title":"Profiling the SARS-CoV-2-specific T-cell response","volume":"24","author":"Geers","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129073_bb0295","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1473-3099(23)00140-8","article-title":"Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial","volume":"23","author":"Tan","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129073_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chom.2023.11.010","article-title":"Pre-existing SARS-2-specific T cells are predicted to cross-recognize BA.2.86","volume":"32","author":"Sette","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2026.129073_bb0305","series-title":"Effects of SARS-CoV-2 Omicron BA.1 spike mutations on T-cell epitopes in mice","first-page":"1","author":"Wang","year":"2023"},{"key":"10.1016\/j.vaccine.2026.129073_bb0310","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1080\/22221751.2021.1978823","article-title":"Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses","volume":"10","author":"Aparicio","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2026.129073_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-023-02137-5","article-title":"Discrimination of SARS-CoV-2 omicron variant and its lineages by rapid detection of immune-escape mutations in spike protein RBD using asymmetric PCR-based melting curve analysis","volume":"20","author":"Kong","year":"2023","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2026.129073_bb0320","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S1473-3099(25)00308-1","article-title":"Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1","volume":"25","author":"Guo","year":"2025","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:47:53Z","timestamp":1794930473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S0264410X26008820"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129073"}}